Heart Device Maker Shockwave Medical Is One Of The Best Assets In MedTech Category: Analyst
Portfolio Pulse from Vandana Singh
Shockwave Medical Inc's Q3 earnings beat expectations with a revenue of $186.0 million, a 42% increase, and EPS of $0.92. The company reaffirmed its FY23 revenue guidance of $725 million-$730 million. Despite this, shares are trading lower due to investor expectations and concerns related to China and the U.S. peripheral business. Piper Sandler reaffirms that SWAV is one of the best assets in the MedTech category.
November 07, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Despite strong Q3 earnings, Shockwave Medical's shares are trading lower due to investor expectations and concerns related to China and the U.S. peripheral business.
Shockwave Medical reported strong Q3 earnings, beating expectations. However, the share price is down due to investor expectations and concerns related to China and the U.S. peripheral business. This indicates that despite the strong financial performance, external factors and market sentiment are negatively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100